Texas Compounding Pharmacy Rejects FDA Request To Withdraw Its Products

Texas Compounding Pharmacy Rejects FDA Request To Withdraw Its Products

SILVER SPRING, Md. - A regulatory dispute between the Food and Drug Administration and a Texas compounding pharmacy escalated Aug. 16 when the agency publicly disclosed that the compounder refused a request to recall all of its sterile products because of what the agency called poor quality conditions.

Find full version on lexis Advance®
Access this news story on lexis.com®